Angiotensin Receptor Blockers With Pleiotropic Properties: A New Standard in Cardiovascular Risk Management and Treatment of Hypertension

Rational Pharmacotherapy in Cardiology - Russian Federation
doi 10.20996/1819-6446-2017-13-3-383-390
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Related search

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

Drug Safety
ToxicologyPharmacology
2014English

Angiotensin Receptor Blockers: Rational Prescription Tailored to the Cardiovascular Risk and Comorbidities

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

A Study on Utilization of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Cardiovascular Diseases

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Potential Beneficial Impact of Angiotensin Receptor Blockers on Arterial Stiffness in Hypertension

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Angiotensin Receptor Blockers Use and the Risk of Lung Cancer: A Meta-Analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2015English

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality, Cardiovascular Deaths, and Cardiovascular Events in Patients With Diabetes Mellitus

JAMA Internal Medicine
Internal Medicine
2014English

Angiotensin Receptor Blockers Don't Seem to Increase Risk of MI

BMJ
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy